<VariationArchive VariationID="94104" VariationName="NM_003106.4(SOX2):c.70_89del (p.Asn24fs)" VariationType="Deletion" Accession="VCV000094104" Version="51" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="11" DateLastUpdated="2024-07-29" DateCreated="2015-06-29" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="100004" VariationID="94104">
      <GeneList>
        <Gene Symbol="LOC108281177" FullName="SOX2 5' regulatory region" GeneID="108281177" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181707848" stop="181712914" display_start="181707848" display_stop="181712914" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SOX2" FullName="SRY-box transcription factor 2" GeneID="6657" HGNC_ID="HGNC:11195" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181711925" stop="181714436" display_start="181711925" display_stop="181714436" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181429711" stop="181432223" display_start="181429711" display_stop="181432223" Strand="+" />
          </Location>
          <OMIM>184429</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX2">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SOX2-OT" FullName="SOX2 overlapping transcript" GeneID="347689" HGNC_ID="HGNC:20209" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181056680" stop="181742228" display_start="181056680" display_stop="181742228" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181328150" stop="181459008" display_start="181328150" display_stop="181459008" Strand="+" />
          </Location>
          <OMIM>616338</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003106.4(SOX2):c.70_89del (p.Asn24fs)</Name>
      <CanonicalSPDI>NC_000003.12:181712418:GCGGCGGCGGCAACTCCACCGCGGCGGCGGC:GCGGCGGCGGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q26.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181712419" stop="181712438" display_start="181712419" display_stop="181712438" variantLength="20" positionVCF="181712418" referenceAlleleVCF="GGCGGCGGCGGCAACTCCACC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181430207" stop="181430226" display_start="181430207" display_stop="181430226" variantLength="20" positionVCF="181430206" referenceAlleleVCF="GGCGGCGGCGGCAACTCCACC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>N24fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003106.3" sequenceAccession="NM_003106" sequenceVersion="3" change="c.70_89delAACTCCACCGCGGCGGCGGC">
            <Expression>NM_003106.3:c.70_89delAACTCCACCGCGGCGGCGGC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_719" sequenceAccession="LRG_719" change="g.5497_5516del">
            <Expression>LRG_719:g.5497_5516del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.181430218_181430237del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.181430218_181430237del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.181712430_181712449del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.181712430_181712449del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009080.1" sequenceAccession="NG_009080" sequenceVersion="1" change="g.5497_5516del">
            <Expression>NG_009080.1:g.5497_5516del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003106.4" sequenceAccession="NM_003106" sequenceVersion="4" change="c.70_89del" MANESelect="true">
            <Expression>NM_003106.4:c.70_89del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003097.1" sequenceAccession="NP_003097" sequenceVersion="1" change="p.Asn24fs">
            <Expression>NP_003097.1:p.Asn24fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003106.4" sequenceAccession="NM_003106" sequenceVersion="4" change="c.70_89del20" MANESelect="true">
            <Expression>NM_003106.4:c.70_89del20</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003106.3" sequenceAccession="NM_003106" sequenceVersion="3" change="c.70_89del20">
            <Expression>NM_003106.3:c.70_89del20</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA221966" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="184429.0010" DB="OMIM" />
        <XRef Type="rs" ID="398123693" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003106.4(SOX2):c.70_89del (p.Asn24fs) AND not provided" Accession="RCV000080064" Version="27">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-12-01" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003106.4(SOX2):c.70_89del (p.Asn24fs) AND Anophthalmia/microphthalmia-esophageal atresia syndrome" Accession="RCV001067610" Version="15">
        <ClassifiedConditionList TraitSetID="3485">
          <ClassifiedCondition DB="MedGen" ID="C1859773">Anophthalmia/microphthalmia-esophageal atresia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-08-22" SubmissionCount="6">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003106.4(SOX2):c.70_89del (p.Asn24fs) AND Septo-optic dysplasia sequence" Accession="RCV002293417" Version="2">
        <ClassifiedConditionList TraitSetID="2096">
          <ClassifiedCondition DB="MedGen" ID="C0338503">Septo-optic dysplasia sequence</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003106.4(SOX2):c.70_89del (p.Asn24fs) AND SOX2-related disorder" Accession="RCV004549501" Version="1">
        <ClassifiedConditionList TraitSetID="55472">
          <ClassifiedCondition>SOX2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-04" NumberOfSubmissions="11" NumberOfSubmitters="11" DateCreated="2015-06-29" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16283891</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16892407</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16932809</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18285410</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18831064</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24804704</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26250054</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27206652</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35885948</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SOX2</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="3485" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5530" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Microphthalmia syndromic 3</ElementValue>
                <XRef ID="Microphthalmia+syndromic+3/4787" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microphthalmia and esophageal atresia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia clinical with associated anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia esophageal genital syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AEG syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia microphthalmia esophageal atresia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Anophthalmia/microphthalmia-esophageal atresia syndrome</ElementValue>
                <XRef ID="MONDO:0008799" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MCOPS3</ElementValue>
                <XRef Type="MIM" ID="206900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of SOX2 disorder includes anophthalmia and/or microphthalmia, brain malformations, developmental delay / intellectual disability, esophageal atresia, hypogonadotropic hypogonadism (manifest as cryptorchidism and micropenis in males, gonadal dysgenesis infrequently in females, and delayed puberty in both sexes), pituitary hypoplasia, postnatal growth delay, hypotonia, seizures, and spastic or dystonic movements.</Attribute>
                <XRef ID="NBK1300" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1443" />
                <XRef ID="1443" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2 Disorder</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2 anophthalmia syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2-related eye disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2-Related Eye Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301477</ID>
                <ID Source="BookShelf">NBK1300</ID>
              </Citation>
              <XRef ID="77298" DB="Orphanet" />
              <XRef ID="C1859773" DB="MedGen" />
              <XRef ID="MONDO:0008799" DB="MONDO" />
              <XRef Type="MIM" ID="206900" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="55472" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="53650" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SOX2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">SOX2-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="2096" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4135" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">De morsier syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Septo-optic dysplasia with growth hormone deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypopituitarism and septooptic 'dysplasia'</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Septo-optic dysplasia</ElementValue>
                <XRef ID="HP:0100842" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Septo-optic dysplasia sequence</ElementValue>
                <XRef ID="Septo-optic+dysplasia+sequence/9284" DB="Genetic Alliance" />
                <XRef ID="7611002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HESX1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SOD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7627" />
                <XRef ID="7627" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3157" DB="Orphanet" />
              <XRef ID="C0338503" DB="MedGen" />
              <XRef ID="MONDO:0008428" DB="MONDO" />
              <XRef Type="MIM" ID="182230" DB="OMIM" />
              <XRef Type="primary" ID="HP:0100842" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33918" SubmissionDate="2016-08-11" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="184429.0010_MICROPHTHALMIA, SYNDROMIC 3" title="SOX2, 20-BP DEL, NT70_MICROPHTHALMIA, SYNDROMIC 3" />
        <ClinVarAccession Accession="SCV000033918" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an 11-month-old Mexican girl with bilateral clinical anophthalmia, mild facial dysmorphism, and developmental delay (MCOPS3; 206900), Zenteno et al. (2005) identified heterozygosity for a 20-bp deletion at nucleotide 70 (70del20) of the SOX2 gene, resulting in a frameshift upstream of the HMG box and a premature termination signal 65 codons downstream. The authors noted that the deleted segment was flanked by the short GGCGGC repeat sequence, suggesting slipped-strand misrepairing as the origin of the deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">16283891</ID>
              </Citation>
              <XRef DB="OMIM" ID="206900" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In male monozygotic twins with ocular defects, esophageal atresia, and genital abnormalities, Zenteno et al. (2006) identified heterozygosity for the 70del20 mutation in the SOX2 gene. Both infants had tracheoesophageal fistula, but otherwise exhibited a discordant phenotype: 1 twin had left clinical anophthalmia and bilateral cryptorchidism, whereas the other had normal globes, narrowing of the right palpebral fissure, and no genital abnormalities. The authors stated that this was the first reported case of SOX2 mutation causing a unilateral eye defect and the first example of monozygotic twins discordant for anophthalmia.</Attribute>
              <Citation>
                <ID Source="PubMed">16892407</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 22-year-old female with left clinical anophthalmia and right microphthalmia, learning difficulties, and primary amenorrhea, Kelberman et al. (2006) identified heterozygosity for a de novo 70del20 mutation in the SOX2 gene. Brain MRI revealed an abnormal hypoplastic pituitary gland in a small sella turcica with an absent left eye and optic nerve. Functional analysis of the mutant protein revealed impaired nuclear localization, DNA binding, and transcriptional activation.</Attribute>
              <Citation>
                <ID Source="PubMed">16932809</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Kelberman et al. (2008) identified this deletion (70_89del) in a 14.5-year-old girl who presented with bilateral anophthalmia at birth. Brain MRI showed an arachnoid cyst in the suprasellar area, with right deflection of the pituitary pedunculus. She later developed gonadotropin deficiency with low basal gonadotropin concentrations and poor response to gonadotropin-releasing hormone (GNRH; 152760) stimulation. There was no evidence of learning difficulties.</Attribute>
              <Citation>
                <ID Source="PubMed">18285410</ID>
              </Citation>
              <XRef DB="OMIM" ID="152760" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a girl and 2 boys with bilateral clinical anophthalmia or severe microphthalmia, Schneider et al. (2009) identified the 70del20 mutation in the SOX2 gene. All 3 patients had developmental delay. Neuroimaging showed a hamartoma of the tuber cinereum in the 2-year-old girl, but was normal in the other 2 patients; none had pituitary anomalies. The 2 boys displayed genital anomalies, including micropenis, cryptorchidism, and foreskin adhesion. Other features seen in the 2 boys included a heart murmur in 1 patient and 2-3 toe syndactyly, febrile seizures, and mild pectus excavatum in the other. The girl had a half-sister with unilateral clinical anophthalmia and mental retardation.</Attribute>
              <Citation>
                <ID Source="PubMed">18831064</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <Name>SOX2, 20-BP DEL, NT70</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">20-BP DEL, NT70</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="184429.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MICROPHTHALMIA, SYNDROMIC 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1101625" SubmissionDate="2021-09-24" DateLastUpdated="2015-06-29" DateCreated="2015-06-29">
        <ClinVarSubmissionID localKey="GDXSV:149968" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000566518" DateUpdated="2015-06-29" DateCreated="2015-06-29" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Published functional studies demonstrate a loss of protein function (Kelberman et al., 2006; Suzuki et al., 2014); Not observed in large population cohorts (Lek et al., 2016); Frameshift variant in the C-terminus predicted to result in protein truncation in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 24859618, 17522144, 29371155, 24498598, 26250054, 27206652, 16283891, 16932809, 16892407, 24804704, 18285410, 30450772, 30262714, 31005762, 31278258, 31884615, 33144682)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:409269</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003106.3:c.70_89del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_50_20210924044205</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3950332" SubmissionDate="2021-11-05" DateLastUpdated="2021-11-11" DateCreated="2021-11-11">
        <ClinVarSubmissionID localKey="3-181430206-GGCGGCGGCGGCAACTCCACC-G" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002011992" DateUpdated="2021-11-11" DateCreated="2021-11-11" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27206652</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26250054</ID>
          </Citation>
          <Comment>Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant has been reported as pathogenic (PMID: 27206652, 26250054).Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002066" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001257" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000252" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001510" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000750" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0004322" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001251" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002194" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003106.3:c.70_89del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="206900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10606558</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4924191" SubmissionDate="2022-05-11" DateLastUpdated="2022-05-21" DateCreated="2022-05-21">
        <ClinVarSubmissionID localKey="NM_003106.4:c.70_89del|OMIM:206900" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002512420" DateUpdated="2022-05-21" DateCreated="2022-05-21" Type="SCV" Version="1" SubmitterName="Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein" OrgID="508506" OrganizationCategory="laboratory" OrgAbbreviation="LABO-HIAE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG classification criteria: PVS1 strong, PS4 very strong, PM2 moderate, PM6 strong</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003106.4:c.70_89del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="206900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11461911</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7676023" SubmissionDate="2023-10-17" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="53625175|OMIM:206900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004099054" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center" OrgID="1019" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PVS1, PS2, PS4, PM2</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003106.4:c.70_89del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="206900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13908327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="644913" SubmissionDate="2017-06-30" DateLastUpdated="2019-07-30" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="14458_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000331496" DateUpdated="2019-07-30" DateCreated="2016-12-06" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000111959" DateChanged="2018-02-14" Version="5" />
        </ReplacedList>
        <Classification DateLastEvaluated="2016-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation>
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="-" referenceAllele="AACTCCACCGCGGCGGCGGC" start="181430218" stop="181430237" variantLength="20" />
            <GeneLocation>NM_003106.3:Ex1</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD054424" />
            <XRef DB="dbSNP" ID="398123693" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SOX2</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL005</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4967349" SubmissionDate="2022-06-24" DateLastUpdated="2022-10-29" DateCreated="2022-10-29">
        <ClinVarSubmissionID localKey="NM_003106.4:c.70_89del20|Septo-optic dysplasia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002538979" DateUpdated="2022-10-29" DateCreated="2022-10-29" Type="SCV" Version="1" SubmitterName="Human Developmental Genetics Laboratory, Medical College of Wisconsin" OrgID="242531" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">35885948</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003106.4:c.70_89del20</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Septo-optic dysplasia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">35885948</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11665651</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5042901" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_003106.4:c.70_89del|OMIM:206900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002581010" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="398123693" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003106.4:c.70_89del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="206900" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PS2, PS3_MOD, PS4_MOD</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2398294" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4666821|MedGen:C1859773" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001232678" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18285410</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24804704</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26250054</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27206652</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 94104). This variant is also known as c.70del20. This premature translational stop signal has been observed in individual(s) with bilateral anophthalmia or microphthalmia with or without additional features (PMID: 18285410, 24804704, 26250054, 27206652). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn24Argfs*65) in the SOX2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 294 amino acid(s) of the SOX2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.181430207_181430226del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1859773" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8796576" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="20425881|SOX2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004710394" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The SOX2 c.70_89del20 variant is predicted to result in a frameshift and premature protein termination (p.Asn24Argfs*65). This variant has been reported in multiple unrelated individuals with syndromic microphthalmia, and in at least 2 individuals was reported to have arisen de novo (Zenteno et al. 2005. PubMed ID: 16283891; Suzuki et al. 2014. PubMed ID: 24804704; Chacon-Camacho et al. 2015. PubMed ID: 26250054). In one individual with normal eye size, other findings included facial dysmorphisms, ocular findings (alternating esotropia, inferior oblique overaction and hyperopia), and an enlarging suprasellar lesion (Blackburn et al. 2018. PubMed ID: 30450772). This variant has not been reported in a large population database, indicating this variant is rare. Frameshift variants in SOX2 are expected to be pathogenic and this variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/94104). This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003106.3:c.70_89del20</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SOX2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4044746" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2022-01-29">
        <ClinVarSubmissionID localKey="112931|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002062525" DateUpdated="2024-07-15" DateCreated="2022-01-29" Type="SCV" Version="17" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="3" alternateAllele="G" referenceAllele="GGCGGCGGCGGCAACTCCACC" start="181430206" stop="181430226" variantLength="21" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3950332" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950332" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004322" MappingRef="HP">
        <MedGen CUI="C0349588" Name="Short stature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950332" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="33918" TraitType="Disease" MappingType="Name" MappingValue="MICROPHTHALMIA, SYNDROMIC 3" MappingRef="Preferred">
        <MedGen CUI="C1859773" Name="Anophthalmia/microphthalmia-esophageal atresia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8796576" TraitType="Disease" MappingType="Name" MappingValue="SOX2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="SOX2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950332" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000252" MappingRef="HP">
        <MedGen CUI="C4551563" Name="Microcephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4967349" TraitType="Disease" MappingType="Name" MappingValue="Septo-optic dysplasia" MappingRef="Preferred">
        <MedGen CUI="C0338503" Name="Septo-optic dysplasia sequence" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4044746" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950332" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002194" MappingRef="HP">
        <MedGen CUI="C1837658" Name="Delayed gross motor development" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950332" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001251" MappingRef="HP">
        <MedGen CUI="C0007758" Name="Cerebellar ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4924191" TraitType="Disease" MappingType="XRef" MappingValue="206900" MappingRef="OMIM">
        <MedGen CUI="C1859773" Name="Anophthalmia/microphthalmia-esophageal atresia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950332" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001510" MappingRef="HP">
        <MedGen CUI="C0456070" Name="Growth delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5042901" TraitType="Disease" MappingType="XRef" MappingValue="206900" MappingRef="OMIM">
        <MedGen CUI="C1859773" Name="Anophthalmia/microphthalmia-esophageal atresia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950332" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002066" MappingRef="HP">
        <MedGen CUI="C0751837" Name="Gait ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950332" TraitType="Disease" MappingType="XRef" MappingValue="206900" MappingRef="OMIM">
        <MedGen CUI="C1859773" Name="Anophthalmia/microphthalmia-esophageal atresia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7676023" TraitType="Disease" MappingType="XRef" MappingValue="206900" MappingRef="OMIM">
        <MedGen CUI="C1859773" Name="Anophthalmia/microphthalmia-esophageal atresia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950332" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000750" MappingRef="HP">
        <MedGen CUI="C0454644" Name="Delayed speech and language development" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2398294" TraitType="Disease" MappingType="XRef" MappingValue="C1859773" MappingRef="MedGen">
        <MedGen CUI="C1859773" Name="Anophthalmia/microphthalmia-esophageal atresia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950332" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001257" MappingRef="HP">
        <MedGen CUI="C0026838" Name="Spasticity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1101625" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="644913" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

